OBJECTIVES:
The objective of this study is to determine the differences in post-operative urinary retention, and sling complications among patients who underwent an isolated retropubic suburethral sling placement, tensioned with a Babcock compared to Kelly clamp. MATERIALS AND METHODS: This is a retrospective chart review of all isolated retropubic suburethral slings (RPS) (Gynecare, Somerville NJ; Boston Scientific, Boston, MA) performed from December 2010 through April 2016 by five fellowship-trained urogynecologists at two institutions. Slings were tensioned with either a Babcock or a Kelly clamp. For the Babcock tensioning method, a Babcock was used to grasp a 3 mm midline fold of mesh, slack was removed from the sling and sheath until the Babcock was in contact with the suburethral tissue (RPS-B). For the Kelly tensioning method, a Kelly was placed between the sling and suburethral tissue and slack was removed from the sling and sheath until desired tension was achieved (RPS-K). Patient's baseline characteristics and pre-operative urodynamic test results were collected. The primary outcome was post-operative length of catheterization. Secondary outcomes included post-operative post-void residual (PVR) and post-operative complications, including sling erosion or revision. We reviewed 270 charts, 79 at one institution, and 191 at the other. Institution one used primarily the RPS-B method (88.6%), while institution two used primarily the RPS-K method (89.0%). Five slings were tensioned with Hagar dilators, one was tensioned with Metzenbaum scissors, and for 24 procedures, and there was no documentation of the method of tensioning. These patients were excluded from analysis. RESULTS: Age, parity, menopausal status, and pre-operative overactive bladder symptoms were not significantly different between RPS-B and RPS-K groups (all P 0.20). There was a significant difference in BMI between the RPS-B (26.3) and RPS-K (28.4) groups (P ¼ 0.008). More patients in the RPS-B (35.7%) group had a history of pelvic organ prolapse surgery than the RPS-K (4.1%) group. Most patients in the RPS-B (65.7%) and RPS-K (71.2%) passed a voiding trial on the day of surgery (P ¼ 0.40). PVR at the two-week and six-week post-operative visits was not significantly different between the two groups. Mesh erosions were significantly higher in the RPS-K group (3.1%) compared to the RPS-B (0%) (P ¼ 0.045), and sling takedowns slightly higher in the RPS-K (2.4%) group compared to RPS-B (1.4%) although not statistically significant (P ¼ 1.0). The incidence of post-operative urinary frequency was comparable in the RPS-B (17.4%) and RPS-K (18.6%) groups. CONCLUSION: This retrospective review demonstrates that the Babcock and Kelly clamp tensioning techniques appear to be comparable, with a low incidence of prolonged post-operative catheterization. Most patients in both groups had their catheters removed on the day of surgery. Post void residuals were similar at the two-week and six-week post-operative visits. Post-operative complications of sling takedown and urinary urgency also appear to be similar, although mesh erosion rate appears to be higher with the Kelly clamp technique.
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OBJECTIVES:
The frequency of orthopedic joint replacement increases with advancing age. Similarly, lower urinary tract symptoms (LUTS) are known to increase in this older population (Norby, 2006) . The prevalence of LUTS in patients scheduled to undergo joint replacement surgery is unknown. The presence of pre-existing LUTS, such as urinary tract infections (UTIs) and urinary retention, may contribute to the morbidity of joint replacement surgery, such as postoperative infections. The primary aim of this study is to evaluate the prevalence of LUTS in patients undergoing knee and hip joint replacement arthroplasty surgery. MATERIALS AND METHODS: This is a prospective cohort study. Patients scheduled to undergo orthopedic knee or hip replacement surgery at Hartford Hospital were recruited continuously between June 2015 and December 2015, inclusive. Consenting patients completed the validated International Consultation on Incontinence Modular Questionnaire (ICIQ) e Female Lower Urinary Tract Symptoms (FLUTS) and supplementary questions related to UTIs and urinary retention. In addition, they completed validated Hip disability and Osteoarthritis Outcome Score (HOOS) or Knee disability and Osteoarthritis Outcome Score (KOOS) to assess the severity of their joint dysfunction (100 ¼ no dysfunction, 0 ¼ extreme dysfunction). All surveys were completed preoperatively, and then again at 3 months postoperatively. RESULTS: One hundred twenty-one women were recruited to the study. Thirty-nine patients (33%) underwent hip replacement and 82 patients (67%) underwent knee replacement. When comparing hip arthroplasty and knee arthroplasty patients, there was no significant difference in ICIQ-FLUTS scores or in patient-reported bladder symptoms at the baseline or 3-month postoperative time points. Filling symptoms (p ¼ 0.009) and Total voiding symptoms (p ¼ 0.014) were significantly correlated with joint dysfunction scores (KOOS) for knee patients at baseline, but this did not persist at the 3-month time-point and was not true for hip patients. Joint dysfunction scores were significantly improved for all patients between baseline and 3-months postoperatively. CONCLUSION: In this prospective study, worse knee function was correlated with worse ICIQ-FLUTS scores prior to surgery but not 3-months after surgery. In general, joint replacement surgery does not appear to be significantly correlated with lower urinary tract symptoms. Larger prospective and anatomic studies may be useful in evaluating the impact of severe joint dysfunction on pelvic floor physiology.
DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS:
Krista M. Reagan: Nothing to disclose; David M. O'Sullivan: Nothing to disclose; Elena Tunitsky-Bitton: Nothing to disclose. 
OBJECTIVES:
To describe surgeons' current practices on InterStimÒ programming after initial implantation and provider knowledge of programming parameters.
MATERIALS AND METHODS:
We administered an anonymous survey to surgeon attendees at the Society of Gynecologic Surgeons 42nd Annual Scientific Meeting. The survey queried characteristics of the surgeons and their practice, experience, and training with InterStimÒ implantation and programming. We also queried which clinical circumstances are important to the surgeon when deciding to reprogram an InterStimÒ and how they decide to make programming changes. The survey tested the respondents with knowledgebased questions about programming parameters. RESULTS: One hundred thirty-five of four hundred seven surgeon attendees (33%) replied to the survey with 124 included surveys. Most were between the ages of 36 and 60 years (76/124, 61%), female (88/124, 71%), practiced in a university-based practice setting (92/124, 74%), and had subspecialty training in female pelvic medicine and reconstructive surgery (FPMRS) (83/124, 67%), while (63/124, 51%) had training in InterStimÒ programming. Responding surgeons were most often from the Northeast (40/124, 32%) and 36% (44/121) reported that they were performing over 16 surgeries of any type per month. While 123 (99%) stated that they offer InterStimÒ as part of their practice, only 102 (82%) replied that they perform their own programming after implantation. 
